Greenup Street Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.98M Sell
25,273
-10,219
-29% -$824K 0.24% 56
2026
Q1
$3.08M Buy
35,492
+19,325
+120% +$1.85M 0.43% 42
2025
Q4
$1.55M Buy
16,167
+2,458
+18% +$239K 0.22% 59
2025
Q3
$1.31M Buy
+13,709
New +$1.26M 0.2% 65
2025
Q1
Sell
-28,886
Closed -$2.31M 109
2024
Q4
$2.31M Buy
28,886
+1,502
+5% +$130K 0.46% 37
2024
Q3
$2.47M Sell
27,384
-316
-1% -$26.6K 0.51% 42
2024
Q2
$2.18M Buy
27,700
+2,822
+11% +$231K 0.51% 39
2024
Q1
$2.17M Buy
+24,878
New +$2.12M 0.54% 40

Other funds holding MDT

Greenup Street Wealth Management's MDT Position: Q2 2026 in Review

Greenup Street Wealth Management reduced its Medtronic (MDT) stake by 29% in Q2 2026, selling an estimated $824K and leaving 25,273 shares worth $1.98M. The position accounts for 0.24% of the portfolio, ranked #56.

Greenup Street Wealth Management first reported a position in MDT in Q1 2024 and has held it in 8 quarters since. The position peaked at $3.08M in Q1 2026. 794 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Greenup Street Wealth Management held 25,273 shares of Medtronic worth $1.98M as of Q2 2026.
  • Greenup Street Wealth Management sold 10,219 Medtronic shares in Q2 2026, an estimated $824K.
  • Medtronic made up 0.24% of Greenup Street Wealth Management's portfolio in Q2 2026, its #56 holding.
  • Greenup Street Wealth Management first reported a position in Medtronic in Q1 2024 and has held it in 8 quarters since.
  • Greenup Street Wealth Management's Medtronic position peaked at $3.08M in Q1 2026.
  • 794 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Greenup Street Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.